Nuvation Bio Inc (NUVB) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Nuvation Bio Inc stock $2.97, price $3.84, that is 22.7% below the price, quality 45 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Nuvation Bio Inc
NUVB · USExpensive (fair value 23% below the price), weak company and price moving sideways: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range $0.9640 – $10.05 · fair‑value band $2.23 – $3.71 · the $3.84 price screens above the $2.97 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Nuvation Bio is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer.
Show moreShow less
It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo.
The company was founded in 2018 and is headquartered in New York, New York.
Stock analysis
Nuvation Bio Inc (NUVB) currently trades at $3.84, while our estimate is $2.97, 23% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: $2.23 (bear) to $3.71 (bull), the price of $3.84 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 45/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Nuvation Bio Inc reported revenue of $62.9M in FY2025 versus $0 in FY2021. Reported net income was −$205M in FY2025.
Key figures
Market cap $1.3B Small · P/S ratio 9.78 · EPS (TTM) $−0.4400 · Net margin −88.2% · Return on equity −47.8% · Return on assets (EBIT) −38.3% (5-year average) · Operating margin −161% · Revenue (TTM) $170M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 60% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −23%, NUVB screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, one officer or director bought shares worth $118,250, on Jun 9, 2026. Over the same period, 4 people sold shares worth $2.1M.
- SaleGary HattersleyCHIEF SCIENTIFIC OFFICER2× since Nov 20, 2025: 469,051 shares, avg. $7.20$3.4MAug 19, 2026
- SaleKerry WentworthCHIEF REGULATORY OFFICER3× since Apr 6, 2026: 299,750 shares, avg. $4.90$1.5MJun 23, 202610b5-1 plan
- SaleStacy MarkelCHIEF PEOPLE OFFICER125,000 shares at $6.03$753,750Jun 23, 202610b5-1 plan
- SalePhilippe SauvageChief Financial Officer47,668 shares at $6.01$286,485Jun 23, 202610b5-1 plan
- BuyRobert MashalDirector25,000 shares at $4.73$118,250Jun 9, 2026
- SaleDongfang LiuCHIEF MEDICAL OFFICER5× since Nov 17, 2025: 270,000 shares, avg. $6.92$1.9MApr 17, 2026
- SaleDavid C. HanleyCHIEF TECHNICAL OPERATIONS200,000 shares at $7.14$1.4MNov 19, 2025
Plus 5 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗
Revenue & earnings trend
Recent news
- Nuvation Bio And 2 More Penny Stocks To Watch
- Nuvation Bio Inc (NUVB) Q3 2026 Earnings Call Highlights: IBTROZI Revenue Climbs 18% as ...
- Nuvation Bio And 2 Penny Stocks To Watch
Compare Nuvation Bio Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 847 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- PEG ratio by industry
- Revenue growth by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $952.40 | $1,275 | +34% | vs NUVB |
| Vertex Pharmaceuticals Incorporated VRTX | $537.79 | $592.46 | +10% | vs NUVB |
| Samsung Biologics Co 207940 | 1,423,000 KRW | 1,552,100 KRW | +9% | vs NUVB |
| argenx SE ARGX | $950.95 | $908.40 | −4% | vs NUVB |
| CSL Limited CSL | A$199.55 | A$186.49 | −7% | vs NUVB |
| Moderna, Inc MRNA | $215.27 | $135.64 | −37% | vs NUVB |
| BeOne Medicines AG 6160 | HK$249.40 | HK$152.92 | −39% | vs NUVB |
| Revolution Medicines, Inc RVMD | $166.87 | $88.78 | −47% | vs NUVB |
| Celltrion, Inc 068270 | 214,500 KRW | 74,945 KRW | −65% | vs NUVB |
| Royalty Pharma plc RPRX | $68.53 | $19.01 | −72% | vs NUVB |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Nuvation Bio Inc (NUVB) overvalued or undervalued?
What is the fair value of NUVB?
What is the quality score of NUVB?
What is the price target for Nuvation Bio Inc (NUVB)?
What is the Nuvation Bio Inc stock forecast for 2026?
What is the revenue of Nuvation Bio Inc (NUVB)?
What is the intrinsic value of Nuvation Bio Inc (NUVB)?
Is Nuvation Bio Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of NUVB?
How much is Nuvation Bio Inc worth?
What do the bullish and bearish scenarios say about NUVB?
How solid is the balance sheet of Nuvation Bio Inc (NUVB)?
How far is NUVB from its 52-week high?
Which stocks are comparable to Nuvation Bio Inc?
Is Nuvation Bio Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Nuvation Bio Inc (NUVB)?
What should I pay attention to with Nuvation Bio Inc right now?
Key figures of Nuvation Bio Inc
How large is the market capitalisation of Nuvation Bio Inc (NUVB)?
What is the P/S ratio of Nuvation Bio Inc (NUVB)?
What are the earnings per share of Nuvation Bio Inc (NUVB)?
What is the net margin of Nuvation Bio Inc (NUVB)?
What is the return on equity of Nuvation Bio Inc (NUVB)?
What is the EBIT return on assets of Nuvation Bio Inc (NUVB)?
What is the operating margin of Nuvation Bio Inc (NUVB)?
How fast is revenue growing at Nuvation Bio Inc (NUVB)?
How much free cash flow does Nuvation Bio Inc (NUVB) generate?
How much net cash does Nuvation Bio Inc (NUVB) hold?
Watch Nuvation Bio Inc in the live analysis
One click puts Nuvation Bio Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.